Proactive Investors - Run By Investors For Investors

Focusrite Plc reports growth across all its key regions as profits soar

Tim Carroll, chief executive of Focusrite plc (LON:TUNE), spoke to Proactive London's Andrew Scott following the release of its results for the year to the end of August 2018.

Group revenue grew by 13.7% to £75.1 million while underlying earnings grew by 18.1% to £15.5 million.

Five new products were launched over the year.

 
Meet Clinigen Group PLC, MaxCyte, Cello Health PLC, Oncimmune and Silence Therapeutics PLC at our event, London , 11 July 2019. Register here »
View full TUNE profile View Profile

Focusrite plc Timeline

Article
January 05 2016

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use